https://www.hmpgloballearningnetwork.com/site/onc/news/ipilimumab-added-nivolumab-does-not-improve-outcomes-refractory-anal-cancer
Results from part B of the phase 2 NCI9673 trial showed that adding ipilimumab to nivolumab did not significantly improve survival or response outcomes in...
improve outcomesipilimumabaddednivolumabrefractory
https://www.openpr.com/news/1047971/metastatic-hormone-refractory-prostate-cancer-market-size-share-industry-trends-and-forecast-2017-2025.html
Press release - MarketResearchReports.biz - Metastatic Hormone Refractory Prostate Cancer Market Size & Share - Industry Trends and Forecast 2017 - 2025 -...
prostate cancermarket sizemetastatichormonerefractory
https://www.mdanderson.org/newsroom/patients-with-refractory-metastatic-colorectal-cancer-experience-survival-benefits-with-fruquintinib.h00-159542901.html
Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that the targeted therapy fruquintinib significantly improved...
metastatic colorectal cancerpatientsrefractoryexperiencesurvival
https://www.sciencedaily.com/releases/2025/05/250507125710.htm
A new class of molecules capable of killing the cancer cells that are refractory to standard treatments and responsible for recurrence has just been developed....
new classcancer cellsmoleculesrefractory
https://www.texaschildrens.org/departments/cancer-and-hematology-center/clinical-trials-and-novel-therapies/cobimetinib-refractory
The purpose of this research study is to learn whether cobimetinib is safe and effective in subjects diagnosed with LCH, LCH-ND, RDD, JXG and ECD which may...
langerhans cell histiocytosiscancerhematologycentercobimetinib
https://stanfordhealthcare.org/trials/s/NCT00718809.html
Stanford Health Care delivers the highest levels of care and compassion. SHC treats cancer, heart disease, brain disorders, primary care issues, and many more.
saracatinibtreatingpatientsrelapsedrefractory